A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation

被引:34
作者
Malagelada, JR [1 ]
机构
[1] Autonomous Univ Barcelona, Hosp Univ Vall dHebron, Digest Syst Res Unit, Barcelona 08035, Spain
关键词
diagnosis; positive diagnosis; irritable bowel syndrome; diagnostic criteria; IBS-C;
D O I
10.1111/j.1368-5031.2005.00744.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder. Characterised by abdominal pain or discomfort, bloating and altered bowel habit, IBS is a chronic recurring condition, typically affecting up to 15% of the Western population, IBS can be subclassified into IBS with constipation (IBS-C), IBS with diarrhoea (IBS-D), or IBS with alternating constipation or diarrhoea symptoms (IBS-A). Conventional clinical diagnosis focuses on excluding all potential organic causes of patient symptoms. However, a positive diagnosis of IBS may be estiblished using published criteria Such as the Manning and/or Rome criteria. While these methods are useful to identify, patients with IBS who are suitable for enrolment into clinical trials, the criteria are relatively complex and not readily applicable to general practice. In this review we present an 'identify, eliminate, probe' algorithm that may be appropriate to establish a positive diagnosis of patients with IBS-C, as symptoms characteristic of patients in this IBS subgroup are least likely to be confused with symptoms reflecting serious organic disease.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 42 条
  • [1] *ACG, 2002, AM J GASTROENTEROL, V97, pS1
  • [2] Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria
    Badia, X
    Mearin, F
    Balboa, A
    Baró, E
    Caldwell, E
    Cucala, M
    Díaz-Rubio, M
    Fueyo, A
    Ponce, J
    Roset, M
    Talley, NJ
    [J]. PHARMACOECONOMICS, 2002, 20 (11) : 749 - 758
  • [3] Bentkover JD, 1999, CAN J GASTROENTEROL, V13, p89A
  • [4] Management of the irritable bowel syndrome
    Camilleri, M
    [J]. GASTROENTEROLOGY, 2001, 120 (03) : 652 - 668
  • [5] Economic burden of irritable bowel syndrome - Proposed strategies to control expenditures
    Camilleri, M
    Williams, DE
    [J]. PHARMACOECONOMICS, 2000, 17 (04) : 331 - 338
  • [6] Is there a SERT-ain association with IBS?
    Camilleri, M
    [J]. GUT, 2004, 53 (10) : 1396 - 1399
  • [7] Irritable bowel syndrome
    Camilleri, M
    Choi, MG
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) : 3 - 15
  • [8] Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome
    Camilleri, M
    Heading, RC
    Thompson, WG
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (08) : 1407 - 1430
  • [9] Review article: irritable bowel syndrome - an evidence-based approach to diagnosis
    Cash, BD
    Chey, WD
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (12) : 1235 - 1245
  • [10] Cash BD, 2002, AM J GASTROENTEROL, V97, P2812